UK ANDROMEDA-Shock-2 RCT

计划入组 25 人 · 首次发布于 2024 年 4 月 16 日

The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.

计划入组 26,600 人 · 首次发布于 2015 年 12 月 1 日

Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study

计划入组 424 人 · 首次发布于 2017 年 3 月 13 日

Andromeda Biotech Ltd.

Israel

Andramed GmbH

Germany

Quotient Sciences and Intrepid Labs Form Strategic Partnership to Accelerate AI-Guided Drug Formulation Development

Eli Lilly Expands Digital Health Partnership with Evidation to Advance Patient-Generated Data Analytics

FDA Approves Sanofi's Multaq for Atrial Fibrillation Patients, Marking First New Treatment in Two Decades